Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 4 × Osteonecrosis × Plasma cell × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Multiple Myeloma 45 Neoplasms, Plasma Cell 5 Lymphoma 4 Waldenstrom Macroglobulinemia 3 Neoplasms 3 Hematologic Neoplasms 3 Recurrence 2 Myelodysplastic Syndromes 2 Lymphoma, Non-Hodgkin 2 Leukemia, Lymphocytic, Chronic, B-Cell 2 Venous Thromboembolism 1 Stomatitis 1 Skin Neoplasms 1 Prostatic Neoplasms 1 Precursor Cell Lymphoblastic Leukemia-Lymphoma 1 Pneumonia, Pneumococcal 1 Pneumococcal Infections 1 Peripheral Nervous System Diseases 1 Pain 1 Osteoporosis 1 Osteonecrosis 1 Osteolysis 1 Myeloproliferative Disorders 1 Multiple Sclerosis 1 Lymphoma, Mantle-Cell 1 Lymphoma, Large-Cell, Immunoblastic 1 Lymphoma, Large-Cell, Anaplastic 1 Lymphoma, Large B-Cell, Diffuse 1 Lymphoma, Follicular 1 Lymphoma, B-Cell, Marginal Zone 1

Interventions

Zoledronic Acid 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02286830 2023-02-17

Magnolia

Odense University Hospital

Phase 4 Completed

Multiple Myeloma, Osteolysis, Osteonecrosis

Data powered by HemOnc (CC BY 4.0) Colophon ⚡